Cerci, Kubra, and Pusem Patir. “Ruxolitinib As a Therapy Choice for Refractory Pruritus in a Patient With Essential Thrombocythemia With CALR Mutation”. Global Journal of Medical and Clinical Case Reports 10, no. 1 (January 25, 2023): 001–002. Accessed January 1, 2025. https://www.organscigroup.com/gjmccr/article/view/GJMCCR-10-267.